Royalty Pharma PLC (RPRX)
27.72
-0.26
(-0.93%)
USD |
NASDAQ |
Apr 25, 10:39
Royalty Pharma Total Liabilities (Quarterly): 6.298B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.298B |
| September 30, 2023 | 6.270B |
| June 30, 2023 | 7.308B |
| March 31, 2023 | 7.252B |
| December 31, 2022 | 7.288B |
| September 30, 2022 | 7.256B |
| June 30, 2022 | 7.332B |
| March 31, 2022 | 7.237B |
| December 31, 2021 | 7.267B |
| Date | Value |
|---|---|
| September 30, 2021 | 7.346B |
| June 30, 2021 | 6.110B |
| March 31, 2021 | 6.077B |
| December 31, 2020 | 6.124B |
| September 30, 2020 | 6.192B |
| June 30, 2020 | 6.291B |
| March 31, 2020 | 6.209B |
| December 31, 2019 | 6.308B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.077B
Minimum
Mar 2021
7.346B
Maximum
Sep 2021
6.716B
Average
6.308B
Median
Dec 2019
Total Liabilities (Quarterly) Benchmarks
| Viatris Inc | 27.22B |
| Walgreens Boots Alliance Inc | 68.84B |
| Pacira BioSciences Inc | 704.26M |
| Amphastar Pharmaceuticals Inc | 873.49M |
| Maravai LifeSciences Holdings Inc | 697.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.38B |
| Shareholders Equity (Quarterly) | 6.526B |
| Debt to Equity Ratio | 0.9401 |
| Current Ratio | 7.896 |
| Net Debt Paydown Yield | 1.56% |